Literature DB >> 35484468

Development and validation of ischemia risk scores.

Robert J H Miller1,2, Alan Rozanski1,3,4, Piotr J Slomka1, Donghee Han1, Heidi Gransar1, Sean W Hayes1, John D Friedman1, Louise E J Thomson1, Daniel S Berman5.   

Abstract

BACKGROUND: The likelihood of ischemia on myocardial perfusion imaging is central to physician decisions regarding test selection, but dedicated risk scores are lacking. We derived and validated two novel ischemia risk scores to support physician decision making.
METHODS: Risk scores were derived using 15,186 patients and validated with 2,995 patients from a different center. Logistic regression was used to assess associations with ischemia to derive point-based and calculated ischemia scores. Predictive performance for ischemia was assessed using area under the receiver operating characteristic curve (AUC) and compared with the CAD consortium basic and clinical models.
RESULTS: During derivation, the calculated ischemia risk score (0.801) had higher AUC compared to the point-based score (0.786, p < 0.001). During validation, the calculated ischemia score (0.716, 95% CI 0.684- 0.748) had higher AUC compared to the point-based ischemia score (0.699, 95% CI 0.666- 0.732, p = 0.016) and the clinical CAD model (AUC 0.667, 95% CI 0.633- 0.701, p = 0.002). Calibration for both ischemia scores was good in both populations (Brier score  < 0.100).
CONCLUSIONS: We developed two novel risk scores for predicting probability of ischemia on MPI which demonstrated high accuracy during model derivation and in external testing. These scores could support physician decisions regarding diagnostic testing strategies.
© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Cardiac stress testing; Coronary artery disease; Myocardial ischemia; SPECT myocardial perfusion imaging

Year:  2022        PMID: 35484468     DOI: 10.1007/s12350-022-02976-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  4 in total

1.  Comparison of diabetes to other prognostic predictors among patients referred for cardiac stress testing: A contemporary analysis from the REFINE SPECT Registry.

Authors:  Daniel S Berman; Piotr J Slomka; Donghee Han; Alan Rozanski; Heidi Gransar; Evangelos Tzolos; Robert J H Miller; Tali Sharir; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Joanna X Liang; Lien-Hsin Hu; Damini Dey
Journal:  J Nucl Cardiol       Date:  2021-11-10       Impact factor: 3.872

2.  Visually estimated coronary artery calcium score improves SPECT-MPI risk stratification.

Authors:  Cvetan Trpkov; Alexei Savtchenko; Zhiying Liang; Patrick Feng; Danielle A Southern; Stephen B Wilton; Matthew T James; Erin Feil; Ilias Mylonas; Robert J H Miller
Journal:  Int J Cardiol Heart Vasc       Date:  2021-06-19

3.  Diagnostic safety of a machine learning-based automatic patient selection algorithm for stress-only myocardial perfusion SPECT.

Authors:  Evann Eisenberg; Robert J H Miller; Lien-Hsin Hu; Richard Rios; Julian Betancur; Peyman Azadani; Donghee Han; Tali Sharir; Andrew J Einstein; Sabahat Bokhari; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Joanna X Liang; Yuka Otaki; Balaji K Tamarappoo; Damini Dey; Daniel S Berman; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2021-07-06       Impact factor: 3.872

Review 4.  Diagnostic performance of cardiac imaging methods to diagnose ischaemia-causing coronary artery disease when directly compared with fractional flow reserve as a reference standard: a meta-analysis.

Authors:  Ibrahim Danad; Jackie Szymonifka; Jos W R Twisk; Bjarne L Norgaard; Christopher K Zarins; Paul Knaapen; James K Min
Journal:  Eur Heart J       Date:  2017-04-01       Impact factor: 35.855

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.